Oraya Therapeutics wins award for eye drug delivery system; Gold nanoparticle breakthrough published;

> Fierce 15 company Oraya Therapeutics won silver at the Annual Medical Design Excellence Awards for its IRay Radiotherapy System to treat wet age-related macular degeneration. The device reduces or sometimes eliminates the need for injections of anti-VEGF (vascular endothelial growth factor) medication. More

> German academics have published the results of their study of drug-delivering gold nanoparticles in Nature Nanotechnology. "Our results show that even nanoparticle-conjugates that appear highly stable can change their properties when deployed in the human body," said lead researcher Dr. Wolfgang Kreyling. "The study will thus have an influence on future medical applications as well as on the risk evaluation of nanoparticles in consumer products and in science and technology." More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.